After confirming the successful implantation of PBMCs, the mice with GVHD were divided into three groups (Figure S7), respectively injected with induced CD1c+ B cells, CD1c− B cells, or PBS (control) via tail vein (Figure 5A). This evidence concerns the gene CD1C and graft versus host disease.